HALOPERIDOL AND REDUCED-HALOPERIDOL CONCENTRATIONS IN PLASMA FROM CHRONIC-SCHIZOPHRENIC PATIENTS

被引：3
|
作者：
AYMARD, N
LEYRIS, A
TOFFIS, V
VIALA, A
EPINETTE, C
DELTEIL, P
机构：
[1] UNIV PARIS 05,PHARMACOL LAB,F-75270 PARIS 06,FRANCE
[2] CHS ST ANNE,UNITE PHARMACOL,F-75014 PARIS,FRANCE
[3] CHS ST ANNE,SERV SANTE MENTALE,UNITE GEORGES CABANIS,F-75014 PARIS,FRANCE
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 183卷 / 06期
关键词：
D O I：
10.1016/0014-2999(90)93854-J
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [41] Effects of olanzapine vs. haloperidol on plasma prolactin in chronic schizophrenic patients
    Smith, RC
    Khandat, A
    Singh, A
    Infante, M
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 132S - 132S
  • [42] TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS WITH HALOPERIDOL AND CHLORPROMAZINE COMBINED
    JONES, B
    LEHMANN, HE
    SAXENA, BM
    BAN, TA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1968, 10 (06): : 276 - &
  • [43] REDUCED HALOPERIDOL HALOPERIDOL RATIOS IN PLASMA - POLYMORPHISM IN JAPANESE PSYCHIATRIC-PATIENTS
    SOMEYA, T
    TAKAHASHI, S
    SHIBASAKI, M
    INABA, T
    CHEUNG, SW
    TANG, SW
    PSYCHIATRY RESEARCH, 1990, 31 (02) : 111 - 120
  • [44] LONG-TERM THERAPY OF CHRONIC-SCHIZOPHRENIC PATIENTS WITH HALOPERIDOL DECANOATE (HALDOL-JANSSEN DECANOAT - HDD)
    RONCORONI, D
    PSYCHIATRISCHE PRAXIS, 1984, 11 (02) : 56 - 58
  • [45] Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients
    Roh, HK
    Chung, JY
    Oh, DY
    Park, CS
    Svensson, JO
    Dahl, ML
    Bertilsson, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (03) : 265 - 271
  • [46] A CANADIAN MULTICENTER PLACEBO-CONTROLLED STUDY OF FIXED DOSES OF RISPERIDONE AND HALOPERIDOL IN THE TREATMENT OF CHRONIC-SCHIZOPHRENIC PATIENTS
    CHOUINARD, G
    JONES, B
    REMINGTON, G
    BLOOM, D
    ADDINGTON, D
    MACEWAN, GW
    LABELLE, A
    BEAUCLAIR, L
    ARNOTT, W
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1993, 13 (01) : 25 - 40
  • [47] Effects of itraconazole on the steady-state plasma concentrations of haloperidol and its reduced metabolite in schizophrenic patients:: In vivo evidence of the involvement of CYP3A4 for haloperidol metabolism
    Yasui, N
    Kondo, T
    Otani, K
    Furukori, H
    Mihara, K
    Suzuki, A
    Kaneko, S
    Inoue, Y
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (02) : 149 - 154
  • [48] SIMULTANEOUS DETERMINATION OF PLASMA HALOPERIDOL AND ITS METABOLITE REDUCED HALOPERIDOL BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION - PLASMA-LEVELS IN SCHIZOPHRENIC-PATIENTS TREATED WITH ORAL OR INTRAMUSCULAR DEPOT HALOPERIDOL
    ARAVAGIRI, M
    MARDER, SR
    VANPUTTEN, T
    MARSHALL, BD
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 656 (02): : 373 - 381
  • [49] A ONE-YEAR DOSE REDUCTION STUDY IN CHRONIC-SCHIZOPHRENIC INPATIENTS - AMISULPRIDE VS HALOPERIDOL
    BARNES, TRE
    SPELLER, JC
    CURSON, DA
    PANTELIS, C
    ALBERTS, JL
    SCHIZOPHRENIA RESEARCH, 1992, 6 (02) : 107 - 107
  • [50] PLASMA PHENYLETHYLAMINE AND PHENYLALANINE IN CHRONIC-SCHIZOPHRENIC PATIENTS
    SZYMANSKI, HV
    NAYLOR, EW
    KAROUM, F
    BIOLOGICAL PSYCHIATRY, 1987, 22 (02) : 194 - 198
12345